CL - Colgate-Palmolive stock is viewed favorably at Morgan Stanley

2023-05-01 07:05:19 ET

Morgan Stanley reiterated an Overweight rating on Colgate-Palmolive ( NYSE: CL ) on Monday after taking in the consumer products company's consensus-beating earnings report and guidance hike .

Analyst Dara Mohsenian and team continue to see clear near-term upside in 2023 for Colgate-Palmolive ( CL ) on EPS, FX, organic sales, and gross margins. The firm also thinks CL has demonstrated a path to higher and sustainable long-term organic sales growth.

Morgan Stanley raised its price target on Colgate-Palmolive ( CL ) to $89 from $82.

Shares of Colgate-Palmolive ( CL ) traded flat during the premarket session on Monday at $79.80 vs. the 52-week range of $67.84 to $83.81.

More on Colgate-Plmolive:

• Read the latest breakdowns on Colgate-Palmolive from Seeking Alpha analysts
• View the growth metrics
• See the financial and valuation comparisons to sector peers
• Dig into the Seeking Alpha Quant Rating

For further details see: